Satavaptan

DRUG4 trials

Sponsors

Sanofi

Conditions

AscitesHyponatremiaInappropriate ADH SyndromeLiver Cirrhosis

Phase 3

Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)

CompletedNCT00358878

SanofiAscites, Liver Cirrhosis

Start: 2006-07-31End: 2008-12-31Updated: 2016-05-26

Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver

TerminatedNCT00359437

SanofiAscites, Liver Cirrhosis

Start: 2006-07-31End: 2008-10-31Updated: 2016-05-24

Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver

TerminatedNCT00366795

SanofiAscites, Liver Cirrhosis

Start: 2006-08-31End: 2008-12-31Updated: 2016-05-18

A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia

TerminatedNCT00728091

SanofiHyponatremia, Inappropriate ADH Syndrome

Start: 2008-07-31End: 2008-12-31Updated: 2016-05-26